90 related articles for article (PubMed ID: 7254280)
21. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
22. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
[TBL] [Abstract][Full Text] [Related]
23. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
24. Source of increased ferritin in neuroblastoma: studies with concanavalin A-sepharose binding.
Hann HW; Stahlhut MW; Evans AE
J Natl Cancer Inst; 1986 Jun; 76(6):1031-3. PubMed ID: 3458940
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factor in neuroblastoma.
Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
[TBL] [Abstract][Full Text] [Related]
26. [Stage IV-S neuroblastoma].
Mancini AF
Pediatr Med Chir; 1984; 6(2):209-12. PubMed ID: 6531245
[TBL] [Abstract][Full Text] [Related]
27. [Hepatopathy in patients with stage 4S neuroblastoma].
Claviez A; Hero B; Schneppenheim R; Berthold F
Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
[TBL] [Abstract][Full Text] [Related]
28. ["As much as possible"--an outdated concept in advanced neuroblastoma?].
Simon S; Hümmer HP; Carbon R; Klein P
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1056-61. PubMed ID: 9101781
[TBL] [Abstract][Full Text] [Related]
29. Serum ferritin in hepatocellular carcinoma.
Zhou XD; Stahlhut MW; Hann HL; London WT
Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
[TBL] [Abstract][Full Text] [Related]
30. Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group.
Hero B; Kremens B; Klingebiel T; Bender-Götze C; Burdach S; Schrappe M; Berthold F
Klin Padiatr; 1997; 209(4):196-200. PubMed ID: 9293450
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastomas contain iron-rich ferritin.
Iancu TC; Shiloh H; Kedar A
Cancer; 1988 Jun; 61(12):2497-502. PubMed ID: 3365671
[TBL] [Abstract][Full Text] [Related]
32. [Levels of ferritin in serum of patients with lung cancer].
Sakowicz A; Kwiek S; Wiatr E
Pneumonol Alergol Pol; 1991; 59(9-10):38-42. PubMed ID: 1843645
[TBL] [Abstract][Full Text] [Related]
33. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
34. [Neuroblastoma in children under than 1 year of age].
Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous regression of neuroblastoma.
Evans AE; Gerson J; Schnaufer L
Natl Cancer Inst Monogr; 1976 Nov; 44():49-54. PubMed ID: 1030781
[TBL] [Abstract][Full Text] [Related]
36. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
Huang CW; Bai L; Cai JJ; Guo W; Lan L
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
[TBL] [Abstract][Full Text] [Related]
37. Proposal and assessment of Japanese tumor node metastasis postsurgical histopathological staging system for neuroblastoma based on an analysis of 495 cases.
Nakagawara A; Morita K; Okabe I; Uchino J; Ohi R; Iwafuchi M; Matsuyama S; Nagashima K; Takahashi H; Nakajo T
Jpn J Clin Oncol; 1991 Feb; 21(1):1-7. PubMed ID: 2067117
[TBL] [Abstract][Full Text] [Related]
38. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
[TBL] [Abstract][Full Text] [Related]
39. Ferritin in neuroblastoma. Impact of tumor load and blood transfusions.
Potaznik D; de Sousa M; Helson L; Bagin R; Groshen S; Bhalla RB
Cancer Invest; 1985; 3(4):327-38. PubMed ID: 4027755
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation.
Hann HW; Stahlhut MW; Chung LC
Lancet; 1984 Jan; 1(8367):43. PubMed ID: 6140361
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
